drugset / Trial / NCT01115452

Efficacy of Potassium Nitrate Solution in Reducing Dentinal Hypersensitivity

NCT01115452

Phase 2 Completed 32 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

An exploratory study investigating the direct application of potassium nitrate (KNO3) solutions of different concentrations in reducing dentine hypersensitivity.

Timeline

Start
2009-09
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Potassium Nitrate Other / unclassified 2.5 %
Subject Potassium Nitrate Other / unclassified 5 %

Indications